Fresenius Medical Care CEO Ronald Kuerbitz has left the dialysis product and service provider to head up new health care services and technology company agilon health. Fresenius appointed William Valle as his successor, effective January 16.

Since 2014, Valle served as executive vice president responsible for the Dialysis Service Business of Fresenius Medical Care North America (FMCNA), the largest business segment of the company, as well as the Vascular Access business.

Valle joined FMCNA in 2009 with 22 years’ experience in the dialysis industry, holding executive positions at several dialysis companies including Gambro Healthcare, Inc.

Read the full story at Nephrology News.